Showing results (11-20 of 199) with videos related to
Sort By:
Pageof 20
Fundamental & Clinical Pharmacology|November 30, 2005
An overview of the pharmacology and clinical efficacy of indapamide sustained releaseJ Sassard, A Bataillard, H McIntyreJournal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1989
Antihypertensive effect of thromboxane A2 receptor blockade in genetically hypertensive rats of the Lyon strainJ Geoffroy, D Benzoni, J SassardHypertension (Dallas, Tex. : 1979)|March 1, 1982
Urinary prostaglandins in the Lyon strains of hypertensive, normotensive, and low blood pressure ratsD Benzoni, M Vincent, J SassardClinica Chimica Acta; International Journal of Clinical Chemistry|March 19, 1981
Radioimmunoassay for urinary prostaglandins E and F alpha: normal values in different age groupsD Benzoni, M Vincent, J SassardFundamental & Clinical Pharmacology|May 5, 1999
Renal effects of cP450 arachidonate metabolites in the Lyon hypertensive ratG Monneret, J Sassard, D BenzoniClinical Pharmacokinetics|September 24, 1999
Pharmacological properties of indapamide. Rationale for use in hypertensionA Bataillard, P Schiavi, J SassardJournal of Hypertension|July 1, 1994
Decreased cardiac baroreflex sensitivity is not due to cardiac hypertrophy in NG-nitro-L-arginine methyl ester-induced hypertensionP Lantelme, M Lo, J SassardArchives Des Maladies Du Coeur Et Des Vaisseaux|October 12, 2007
[Importance of chromosome 17 in genetically hypertensive rats of the Lyon strain (LH): study of a consomic strain]S Gilibert, J Sassard, A BataillardLa Nouvelle Presse Medicale|June 9, 1979
[Hypertension due to unilateral parenchymatous nephropathy (author's transl)]P Zech, N Pozet, J SassardProstaglandins, Leukotrienes, and Medicine|June 1, 1985
A new radioimmunoassay for urinary thromboxane B2 with prior purification by high performance liquid chromatographyJ Geoffroy, D Benzoni, J SassardPageof 20